Eugene Goldwasser, who isolated and purified erythropoietin in the 1970s, has died, reports The New York Times. He was 88. It later became the basis of Amgen, and the company has made billions of dollars on the anemia drug. "It just continually delighted him that the work he did ended up having an impact on patients," Gary Toback, a colleague of Goldwasser's at the University of Chicago, tells the Times.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.